A review of the newer aromatase inhibitors in the management of metastatic breast cancer

Journal of Clinical Pharmacy and Therapeutics ◽

10.1046/j.1365-2710.1998.00145.x ◽

1998 ◽

Vol 23 (2) ◽

pp. 81-90 ◽

Author(s):

Reddy

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Aromatase Inhibitors ◽

Metastatic Breast

Download Full-text

531P The role of diuretics in treatment of aromatase inhibitors induced musculoskeletal symptoms in women with non metastatic breast cancer

Annals of Oncology ◽

10.1016/s0923-7534(21)00689-x ◽

2016 ◽

Vol 27 ◽

pp. ix172-ix173

Author(s):

A.M. Alhanafy ◽

A.A. Labeeb

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Aromatase Inhibitors ◽

Metastatic Breast ◽

Musculoskeletal Symptoms

Download Full-text

Expression of Estrogen Receptor Beta and Phosphorylation of Estrogen Receptor Alpha Serine 167 Correlate with Progression-Free Survival in Patients with Metastatic Breast Cancer Treated with Aromatase Inhibitors

Oncology ◽

10.1159/000319540 ◽

2010 ◽

Vol 79 (1-2) ◽

pp. 55-61 ◽

Author(s):

Kazuyoshi Motomura ◽

Makoto Ishitobi ◽

Yoshifumi Komoike ◽

Hiroki Koyama ◽

Hideki Nagase ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Metastatic Breast Cancer ◽

Aromatase Inhibitors ◽

Estrogen Receptor Alpha ◽

Estrogen Receptor Beta ◽

Metastatic Breast ◽

Progression Free Survival ◽

Free Survival ◽

Download Full-text

53P Aromatase inhibitor and cyclin-dependent kinase 4/6 inhibitor treated HR+/HER2- metastatic breast cancer differ to those treated with Aromatase inhibitors alone on progression

Annals of Oncology ◽

10.1016/j.annonc.2020.10.073 ◽

2020 ◽

Vol 31 ◽

pp. S1263

Author(s):

I. Weerasena ◽

L. Spalding ◽

H. Martin ◽

A. Redfern

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Aromatase Inhibitor ◽

Aromatase Inhibitors ◽

Metastatic Breast ◽

Cyclin Dependent Kinase

Download Full-text

Evidence for the prevention of bone loss in elderly and old early non-metastatic breast cancer patients treated with aromatase inhibitors

European Geriatric Medicine ◽

10.1016/j.eurger.2017.06.004 ◽

2017 ◽

Vol 8 (5-6) ◽

pp. 408-412

Author(s):

V. Gunmalm ◽

N.R. Jørgensen ◽

B. Abrahamsen ◽

P. Schwarz

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Bone Loss ◽

Cancer Patients ◽

Aromatase Inhibitors ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Prevention Of Bone Loss

Download Full-text

Abstract P2-13-03: Prevalence of non-metastatic breast cancer patients treated with aromatase inhibitors in the United States

10.1158/0008-5472.sabcs12-p2-13-03 ◽

2012 ◽

Author(s):

A Liede ◽

RK Hernandez ◽

M Pirolli ◽

J Quigley ◽

D Quach

Keyword(s):

Breast Cancer ◽

United States ◽

Metastatic Breast Cancer ◽

Cancer Patients ◽

Aromatase Inhibitors ◽

Metastatic Breast ◽

The United States ◽

Breast Cancer Patients

Download Full-text

Fulvestrant 500 mg Versus Exemestane in Postmenopausal Women With Metastatic Breast Cancer Resistant to Adjuvant Nonsteroidal Aromatase Inhibitors in Clinical Practice: A Multicenter Retrospective Study

Clinical Breast Cancer ◽

10.1016/j.clbc.2019.01.015 ◽

2019 ◽

Vol 19 (3) ◽

pp. e452-e458

Author(s):

Yizhao Xie ◽

Yi Li ◽

Yinbin Zhang ◽

Shuqun Zhang ◽

Wei Li ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Clinical Practice ◽

Retrospective Study ◽

Postmenopausal Women ◽

Aromatase Inhibitors ◽

Metastatic Breast ◽

Nonsteroidal Aromatase Inhibitors

Download Full-text

Effect of denosumab administration on low bone mineral density (T-score −1.0 to −2.5) in postmenopausal Japanese women receiving adjuvant aromatase inhibitors for non-metastatic breast cancer

Journal of Bone and Mineral Metabolism ◽

10.1007/s00774-017-0884-x ◽

2017 ◽

Vol 36 (6) ◽

pp. 716-722 ◽

Author(s):

Katsuhiko Nakatsukasa ◽

Hiroshi Koyama ◽

Yoshimi Ouchi ◽

Kouichi Sakaguchi ◽

Yoshifumi Fujita ◽

...

Keyword(s):

Breast Cancer ◽

Bone Mineral Density ◽

Metastatic Breast Cancer ◽

Bone Mineral ◽

Aromatase Inhibitors ◽

Metastatic Breast ◽

Japanese Women ◽

Mineral Density ◽

T Score ◽

Low Bone Mineral Density

Download Full-text

Implications of First-Line Adjuvant Treatment with Aromatase Inhibitors in Recurrent Metastatic Breast Cancer

Clinical Breast Cancer ◽

10.3816/cbc.2004.s.011 ◽

2004 ◽

Vol 5 ◽

pp. S24-S30

Author(s):

Lisa E. Sokolowicz ◽

William J. Gradishar

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Aromatase Inhibitors ◽

Adjuvant Treatment ◽

Metastatic Breast ◽

Download Full-text

A Randomised Trial of Sequential Aromatase Inhibitors (AI) in Postmenopausal Women with Locally Advanced or Metastatic Breast Cancer. The SAINT Trial

http://isrctn.org/> ◽

10.1186/isrctn99515843 ◽

2012 ◽

Author(s):

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Postmenopausal Women ◽

Aromatase Inhibitors ◽

Randomised Trial ◽

Locally Advanced ◽

Metastatic Breast

Download Full-text

The impact of waist-to-hip ratio on clinical outcomes in metastatic breast cancer patients treated with aromatase inhibitors

10.1016/j.breast.2008.01.007 ◽

2008 ◽

Vol 17 (4) ◽

pp. 418-422 ◽

Author(s):

Mehmet Artac ◽

Hakan Bozcuk ◽

Berna Afacan ◽

Mustafa Ozdogan ◽

Mustafa Samur

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cancer Patients ◽

Clinical Outcomes ◽

Aromatase Inhibitors ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Waist To Hip Ratio ◽

Download Full-text